Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

NATerminatedINTERVENTIONAL
Enrollment

888

Participants

Timeline

Start Date

July 28, 2008

Primary Completion Date

April 30, 2016

Study Completion Date

April 5, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

everolimus-eluting stent

Xience V stent

PROCEDURE

coronary artery bypass graft surgery

coronary artery bypass graft surgery

Trial Locations (27)

Unknown

Sir Run Run Shaw Hospital, Hangzhou

Zhongshan Hospital, Shanghai

National Heart Institue, Kuala Lumpur

Sarawak General Hospital, Kuching

Gangwon National Univ. Hospital, Chuncheon

Keimyung University Dongsan Medical Center, Daegu

Yeungnam University Medical Center, Daegu

Konyang University Hospital, Daejeon

Chonnam National University Hospital, Gwangju

Inje University Ilsan Paik Hospital, Ilsan

National Health Insurance Corporation Ilsan Hospital, Ilsan

Gachon University Gil Hospital, Incheon

Inje University Pusan Paik Hospital, Pusan

Pusan National University Yangsan Hospital, Pusan

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Hanyang National University Medical Center, Seoul

Inje University Sanggye Paik Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

Severance Hospital, Seoul

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

St.carollo Hospital, Suncheon

Ulsan University Hospital, Ulsan

Wonju Christian Hospital, Wŏnju

Siriraj Hospital, Bangkok

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Seung-Jung Park

OTHER